blood clots and glp 1 A recent study suggests that GLP-1 medications, commonly prescribed for managing diabetes obesity, may also lower the risk of dangerous clots., The study’s lead author, Dr. Rushad Patell of January 2025: GLP Drugs -

On , we highlight the critical role of lipid profiling in assessing cardiovascular risk and metabolic health

Diabetes Therapy

Start your intake GLP-1 Medications and Autoimmune Thyroid Disease: Current Evidence Clinical literature does not establish that GLP-1 agonists treat Hashimoto's or reduce thyroid antibody levels

(2021) found that TMAO levels remained elevated in the long term treatment of patients with HF who underwent left ventricular assist device (LVAD) implantation or heart transplantation

Studies tracking real-world outcomes show that patients maintaining GLP-1 therapy experience sustained metabolic improvements and weight maintenance even after dose optimization plateaus

Figure 12c illustrates the performance of the proposed model over 30 training epochs, tracking Accuracy, F1 Score, and AUC of the training and validation sets